LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
6.70
-0.07 (-1.03%)
At close: Mar 28, 2025, 4:00 PM
6.58
-0.12 (-1.79%)
After-hours: Mar 28, 2025, 4:55 PM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for LifeStance Health Group stock have an average target of 8.63, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 28.81% from the current stock price of 6.70.
Analyst Consensus: Buy
* Price targets were last updated on Dec 16, 2024.
Analyst Ratings
The average analyst rating for LifeStance Health Group stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +49.25% | Dec 16, 2024 |
| Barclays | Barclays | Sell Maintains $6 → $7 | Sell | Maintains | $6 → $7 | +4.48% | Nov 11, 2024 |
| UBS | UBS | Hold Maintains $9 → $7.5 | Hold | Maintains | $9 → $7.5 | +11.94% | Aug 15, 2024 |
| Barclays | Barclays | Sell Maintains $8 → $6 | Sell | Maintains | $8 → $6 | -10.45% | Aug 9, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $10 | Buy | Reiterates | $10 | +49.25% | Apr 22, 2024 |
Financial Forecast
Revenue This Year
1.44B
from 1.25B
Increased by 15.35%
Revenue Next Year
1.64B
from 1.44B
Increased by 13.86%
EPS This Year
-0.12
from -0.15
EPS Next Year
-0.04
from -0.12
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.5B | 1.7B | 2.0B |
| Avg | 1.4B | 1.6B | 1.9B |
| Low | 1.4B | 1.5B | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 19.4% | 19.3% | 20.9% |
| Avg | 15.4% | 13.9% | 16.0% |
| Low | 9.3% | 7.3% | 9.4% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.08 | 0.01 |
| Avg | -0.12 | -0.04 |
| Low | -0.19 | -0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.